Form D Explorer

Inspect source fieldsReport a record issue

Form D — Aspira Women's Health Inc.

0001493152-25-014101 · filed Sep 18, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$2,950,000
Reported amount sold
$2,950,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Aspira Women's Health Inc.
CIK
926617
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
12117 BEE CAVES ROAD
AUSTIN, Texas 78738
Phone
512-519-0400

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗